We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Outpatient Cardiac Rehabilitation in Austria

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01540006
First Posted: February 28, 2012
Last Update Posted: October 18, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Prof. Josef Niebauer M.D., Ph.D., MBA, Paracelsus Medical University
  Purpose

The aim of this prospective trial is the manifestation of guidelines developed for outpatient cardiac rehabilitation in Austria.

The evaluation of prospective and retrospective data is supposed to give evidence on morbidity and/or mortality advantages compared to patients not participating in cardiac rehabilitation programs.

The database created in this context is supposed to pave the way as instrument to document and comprehend quality and cost effectiveness of outpatient cardiac rehabilitation in Austria as a key for quality management.


Condition Intervention
Heart Disease Other: Physical activity

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Prof. Josef Niebauer M.D., Ph.D., MBA, Paracelsus Medical University:

Primary Outcome Measures:
  • Physical work capacity (PWC) [ Time Frame: 6 weeks ]
    PWC is measuered by gradded exercise test on cycling ergometer before and after rehabilitation.


Enrollment: 1200
Study Start Date: January 2009
Study Completion Date: May 2014
Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Physical activity
    50min of endurance training combined with 45min of calisthenics; 1-3x/week; 6-24 weeks
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Any patients with heart disease willing to participate in an ambulant cardiac rehabilitation.
Criteria

Inclusion Criteria:

  • heart disease

Exclusion Criteria:

  • participation in another study within the previous 6 months
  • Medical conditions which prevent patients from complying with the exercise program
  • Acute infections
  • Hypertrophic cardiomyopathy
  • Pulmonary artery embolism or phlebothrombosis within the previous 6 months
  • Unstable angina pectoris
  • Heart failure (NYHA IV)
  • Hemodynamically unstable arrhythmia
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01540006


Locations
Austria
Department of Sports Medicine, Prevention and Rehabilitation Paracelsus Medical University
Salzburg, Austria, 5020
Sponsors and Collaborators
Paracelsus Medical University
Investigators
Study Chair: Prof. Josef Niebauer, MD, PhD, MBA Paracelsus Medical University
  More Information

Additional Information:
Publications:
Responsible Party: Prof. Josef Niebauer M.D., Ph.D., MBA, Head of institute, Paracelsus Medical University
ClinicalTrials.gov Identifier: NCT01540006     History of Changes
Other Study ID Numbers: UISM-6
First Submitted: February 22, 2012
First Posted: February 28, 2012
Last Update Posted: October 18, 2017
Last Verified: October 2017

Additional relevant MeSH terms:
Heart Diseases
Cardiovascular Diseases